Interest in the intracellular metabolism of purine analogues (adenosine and its derivative) arose after the understanding of the pathophysiology of a specific type of Severe Combined Immunodeficiency (ADA-SCID) found to be the result of an inherited deficiency in adenosine deaminase enzyme 1 (ADA1). This evidence concerns the gene ADA and severe combined immunodeficiency.